drugset / Trial / NCT04137185
Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients
NaSingle-groupOpen-labelTreatment
Summary
Phase I/II Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake Effects For Recombinant Human Thyroid Stimulating Hormone In Post-thyroidectomized Patients
Timeline
- Start
- 2019-06-10
- Primary completion
- 2020-12-29
- Completion
- 2020-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rhTSH | Protein / enzyme biologic | 0.9 mg | Intramuscular |
| Subject | rhTSH | Protein / enzyme biologic | 1.8 mg | Intramuscular |